Literature DB >> 11517384

Persistence of the influenza A/WSN/33 virus RNA at midbrain levels of immunodefective mice.

F Aronsson1, H Karlsson, H G Ljunggren, K Kristensson.   

Abstract

Strains of influenza A virus are known to infect specific subpopulations of neurons in the mouse brain. Here we report that all segments of the genome of the neurotropic influenza A virus, strain WSN/33, can persist in the brains of immunodefective transporter associated with Antigen Processing 1 (TAP1) mutant mice. Ten to 17 months after injection of virus into the olfactory bulbs, viral RNA encoding the nonstructural NS1 protein was detected in sections from the brain at midbrain levels by RT-PCR in almost all animals. Both negative-strand genomic RNA (vRNA) and positive-strand RNA, including mRNA, were found. RNA encoding nucleoprotein and polymerases, which form the replicative complex of the virus, were detected in fewer brains. RNA encoding envelope proteins were found only in occasional brains. No viral cDNA could be identified. This observation shows that certain regions of the brain in immunodefective mice may harbor the genome of influenza A virus including the NS1 gene, the products of which may play a regulatory role in host-cell metabolism.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11517384     DOI: 10.1080/13550280152058771

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  21 in total

1.  Determination of influenza virus proteins required for genome replication.

Authors:  T S Huang; P Palese; M Krystal
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

2.  The ORF, regulated synthesis, and persistence-specific variation of influenza C viral NS1 protein.

Authors:  M Marschall; A Helten; A Hechtfischer; A Zach; C Banaschewski; W Hell; H Meier-Ewert
Journal:  Virology       Date:  1999-01-20       Impact factor: 3.616

Review 3.  Persistence of RNA viruses in the central nervous system.

Authors:  K Kristensson; E Norrby
Journal:  Annu Rev Microbiol       Date:  1986       Impact factor: 15.500

4.  1918 influenza, encephalitis lethargica, parkinsonism.

Authors:  R T Ravenholt; W H Foege
Journal:  Lancet       Date:  1982-10-16       Impact factor: 79.321

5.  Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3'-end processing machinery.

Authors:  Z Chen; Y Li; R M Krug
Journal:  EMBO J       Date:  1999-04-15       Impact factor: 11.598

6.  Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3'end formation of cellular pre-mRNAs.

Authors:  M E Nemeroff; S M Barabino; Y Li; W Keller; R M Krug
Journal:  Mol Cell       Date:  1998-06       Impact factor: 17.970

Review 7.  Neurovirulence of influenza A virus.

Authors:  A C Ward
Journal:  J Neurovirol       Date:  1996-06       Impact factor: 2.643

8.  Type A influenza: postmortem virus isolations from different organs in human lethal cases.

Authors:  V Franková; A Jirásek; B Tůmová
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

9.  Long-term persistence of activated cytotoxic T lymphocytes after viral infection of the central nervous system.

Authors:  S Hawke; P G Stevenson; S Freeman; C R Bangham
Journal:  J Exp Med       Date:  1998-05-18       Impact factor: 14.307

10.  The substantia nigra is a major target for neurovirulent influenza A virus.

Authors:  M Takahashi; T Yamada; S Nakajima; K Nakajima; T Yamamoto; H Okada
Journal:  J Exp Med       Date:  1995-06-01       Impact factor: 14.307

View more
  12 in total

1.  The viral theory of schizophrenia revisited: abnormal placental gene expression and structural changes with lack of evidence for H1N1 viral presence in placentae of infected mice or brains of exposed offspring.

Authors:  S Hossein Fatemi; Timothy D Folsom; Robert J Rooney; Susumu Mori; Tess E Kornfield; Teri J Reutiman; Rachel E Kneeland; Stephanie B Liesch; Kegang Hua; John Hsu; Divyen H Patel
Journal:  Neuropharmacology       Date:  2011-01-26       Impact factor: 5.250

Review 2.  Potential microbial origins of schizophrenia and their treatments.

Authors:  S Hossein Fatemi
Journal:  Drugs Today (Barc)       Date:  2009-04       Impact factor: 2.245

3.  Acute murine H5N1 influenza A encephalitis.

Authors:  Stephanie J Bissel; Brendan M Giles; Guoji Wang; Dane C Olevian; Ted M Ross; Clayton A Wiley
Journal:  Brain Pathol       Date:  2011-09-15       Impact factor: 6.508

Review 4.  Viral infection, inflammation and schizophrenia.

Authors:  Rachel E Kneeland; S Hossein Fatemi
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-02-10       Impact factor: 5.067

5.  Effects on synaptic activity in cultured hippocampal neurons by influenza A viral proteins.

Authors:  Johan Brask; Ashok Chauhan; Russell H Hill; Hans-Gustaf Ljunggren; Krister Kristensson
Journal:  J Neurovirol       Date:  2005-08       Impact factor: 2.643

6.  Residual antigen presentation after influenza virus infection affects CD8 T cell activation and migration.

Authors:  David J Zammit; Damian L Turner; Kimberly D Klonowski; Leo Lefrançois; Linda S Cauley
Journal:  Immunity       Date:  2006-04       Impact factor: 31.745

7.  Viral regulation of aquaporin 4, connexin 43, microcephalin and nucleolin.

Authors:  S Hossein Fatemi; Timothy D Folsom; Teri J Reutiman; Robert W Sidwell
Journal:  Schizophr Res       Date:  2007-11-09       Impact factor: 4.939

8.  Persistence of viral RNA in the brain of offspring to mice infected with influenza A/WSN/33 virus during pregnancy.

Authors:  Fredrik Aronsson; Charlotta Lannebo; Martin Paucar; Johan Brask; Krister Kristensson; Håkan Karlsson
Journal:  J Neurovirol       Date:  2002-08       Impact factor: 2.643

9.  Influenza A virus transactivates the mouse envelope gene encoding syncytin B and its regulator, glial cells missing 1.

Authors:  Linnéa Asp; Christoffer Nellåker; Håkan Karlsson
Journal:  J Neurovirol       Date:  2007       Impact factor: 2.643

Review 10.  The neurodevelopmental hypothesis of schizophrenia, revisited.

Authors:  S Hossein Fatemi; Timothy D Folsom
Journal:  Schizophr Bull       Date:  2009-02-17       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.